Skip to main content
OpenTrials
Completed

NCT Number: NCT00674778

Prospective Registry on Vascular Access in Interventions in Lazio Region

Previous randomised studies showed that radial artery catheterisation for percutaneous cardiovascular procedures has a superior safety profile than femoral access, however the confirmation of these benefits in the real world by a large, specific, observational study is still lacking.

We endeavoured to assess the access site-related outcomes of any percutaneous cardiovascular procedure by designing a prospective registry monitoring a consecutive sample of patients in a short period of time at nine Roman hospitals reflecting the contemporary state of health care.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients undergoing any percutaneous cardiovascular procedure

Exclusion criteria

  • Patients already enrolled in other clinical trials

Treatment and study plan

Any percutaneous cardiovascular procedure

Procedure

Primary outcomes

  1. Cumulative incidence of: (a) major and minor bleedings, (b) access site vascular complications, (c) stroke

    Time frame: in-hospital

Secondary outcomes

  1. Cumulative incidence of (a) death, (b) myocardial infarction or reinfarction

    Time frame: in-hospital

Sponsors and collaborators

Lead sponsor

San Filippo Neri General Hospital

Other

Registry information

Acronym: PREVAIL

Important dates

Study start
2006
Study completion
2006
First posted
May 8, 2008
Registry last updated
May 8, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.